Cart
sales@molnova.com
SGA360
CAS No. 680611-86-3
SGA360( —— )
Catalog No. M24693 CAS No. 680611-86-3
SGA360 is a selective aryl hydrocarbon (Ah) receptor modulator. It exhibits anti-inflammatory properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 111 | In Stock |
|
| 5MG | 132 | In Stock |
|
| 10MG | 217 | In Stock |
|
| 25MG | 330 | In Stock |
|
| 50MG | 460 | In Stock |
|
| 100MG | 669 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSGA360
-
NoteResearch use only, not for human use.
-
Brief DescriptionSGA360 is a selective aryl hydrocarbon (Ah) receptor modulator. It exhibits anti-inflammatory properties.
-
DescriptionSGA360 is a selective aryl hydrocarbon (Ah) receptor modulator. It exhibits anti-inflammatory properties.
-
In Vitro——
-
In VivoSGA360 exhibits anti-inflammatory activity in vivo.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptoraryl hydrocarbon receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number680611-86-3
-
Formula Weight362.3
-
Molecular FormulaC19H17F3N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCOC1=CC(=C(C=C1)C2=NN(C3=C2C=CC=C3C(F)(F)F)CC=C)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Muku G E , Lahoti T S , Murray I A , et al. Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses[J]. Laboratory Investigation, 2017.
molnova catalog
related products
-
PACMA 31
PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.
-
6,7-Dihydroxyflavone
6,7-Dihydroxyflavone is a natural product for research related to life sciences.
-
30-Hydroxygambogic a...
30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines.
